Seth Yakatan

Director/Miembro de la Junta en FITLIFE BRANDS, INC. .

53 años

Health Technology

Consumer Services

Finance

Perfil

Seth Yakatan is the founder of Katan Associates International (founded in 2001), Kalytera Therapeutics, Inc. (founded in 2014), and Claritas Pharmaceuticals, Inc. (founded in 2004).
He holds the title of Partner at Katan Associates International since its founding.
Mr. Yakatan's current jobs include Director at DCI USA, Inc. (since 2005) and Independent Director at FitLife Brands, Inc. (since 2015).
His former jobs include Chief Financial Officer & Director at iSatori, Inc. (2014-2015) and Vice President-Business Development at Invion Ltd.
(2012-2017).
Mr. Yakatan received an MBA from the University of California, Irvine and an undergraduate degree from the University of Denver.

Cargos activos de Seth Yakatan

Empresas	Cargo	Inicio
FITLIFE BRANDS, INC.	Director/Miembro de la Junta	01/09/2015
DCI USA, Inc. DCI USA, Inc. Real Estate DevelopmentFinance DCI USA, Inc. owns and operates income-producing real estate, and makes investments in and provides consulting services to other businesses. The company was founded on June 21, 2000 and is headquartered in Brooklyn, NY.	Director/Miembro de la Junta	01/02/2005
Katan Associates International Katan Associates International Katan Associates International operates as a corporate strategy and finance advisory group which focuses on the global life sciences industry. Its services include consulting, mergers and acquisitions,partnering, and merchant banking. The company was founded by Seth Yakatan and Stanley Yakatan in 2001 and is headquartered in Manhattan Beach, CA.	Fundador	01/04/2001

Todos los cargos activos de Seth Yakatan

Antiguos cargos conocidos de Seth Yakatan.

Empresas	Cargo	Fin
CLARITAS PHARMACEUTICALS, INC.	Fundador	03/08/2017
INVION LIMITED	Corporate Officer/Principal	01/01/2017
ISATORI INC	Director Financiero/CFO	30/09/2015
Kalytera Therapeutics, Inc. /Old/ Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA.	Fundador	-

Ver el detalle de la experiencia de Seth Yakatan.

Formación de Seth Yakatan.

University of California, Irvine	Masters Business Admin
University of Denver	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Seth Yakatan.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	3
INVION LIMITED	Health Technology
FITLIFE BRANDS, INC.	Health Technology
CLARITAS PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	4
DCI USA, Inc. DCI USA, Inc. Real Estate DevelopmentFinance DCI USA, Inc. owns and operates income-producing real estate, and makes investments in and provides consulting services to other businesses. The company was founded on June 21, 2000 and is headquartered in Brooklyn, NY.	Finance
iSatori, Inc. iSatori, Inc. Pharmaceuticals: OtherHealth Technology iSatori, Inc. engages in the market, sale, and distribution of nutritional and dietary supplement products. It offers products through online, catalogs and various retail stores. The company was founded by Stephen D. Adelé in 2001 and is headquartered in Omaha, NE.	Health Technology
Kalytera Therapeutics, Inc. /Old/ Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA.	Health Technology
Katan Associates International Katan Associates International Katan Associates International operates as a corporate strategy and finance advisory group which focuses on the global life sciences industry. Its services include consulting, mergers and acquisitions,partnering, and merchant banking. The company was founded by Seth Yakatan and Stanley Yakatan in 2001 and is headquartered in Manhattan Beach, CA.

Ver las conexiones de la empresa